Pharma

Your Article Summary

See Latest Articles

Bio Companies Low on Venture Capital Cash
PharmExec, 05/07/09

Ernst and Young, on Tuesday, released its massive biotech report detailing changes in the industry over the past 12 months. Alliance deals were the big news of 2008, with numerous transactions worth billions in "biobucks." More recently, though, the global economic crisis has hit home, with venture capital dollars slipping away and smaller cap companies forced to sell or go under.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

Successful purchase of trait platform with extensive product pipeline
BayNews International, 11/06/09

Cell Therapeutics, Inc.s (CTI) Presentation at BIO Investor Forum to be Webcast
Cell Therapeutics, 11/04/09

See All of Biotechnology

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Antigenics Reports Third Quarter 2009 Financial Results
Antigenics, 11/05/09

See All of Financial Reports